Condition
Incretin Effect
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 5 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed5
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06194955Not ApplicableCompletedPrimary
The Effect of GIP, GLP-1 and GLP-2 in Individuals With Genetically Altered Receptor Function
NCT03935841Not ApplicableCompleted
Metabolic Differences of an Oral and Intravenous Dose of 3-hydroxybutyrate (3-OHB).
NCT03348371Not ApplicableCompleted
The Effects of Ethanol on Intestinal Permeability and Gut Hormones
NCT00803296CompletedPrimary
Incretin Effect in Lean and Obese Subjects
NCT00529048CompletedPrimary
Quantification of the Incretin Effect in Healthy Subjects and Patients With Type 2 Diabetes
Showing all 5 trials